Effects of combined nutraceuticals on cell viability, migration, and apoptosis in human colorectal cancer cells

Colorectal cancer (CRC), which comprises cancer of the colon and/or rectum, is the third most commonly diagnosed type of cancer. Due to the occurrence of adverse effects and drug resistance, there is a need to find more effective treatments for CRC. Nutraceuticals regulate various metabolic pathways can modulate multiple biomarkers in cancer cells. The present study examined whether diallyl disulfide (DADS) and sulforaphane (SFN), either alone or in combination, were cytotoxic to human colon cancer cells. We assessed DADS (25-800 µM) and SFN (2-32 µM) effects on cell viability (resazurin assay), cell migration (wound healing), and apoptosis (flow cytometry) in human colon adenocarcinoma cells (Caco-2 and HT-29). Synergistic, additive, and antagonistic effects were determined by the combination index (CI) method. The treatment with SFN alone in high concentration reduced cell viability and suppressed cell migration in both cells. The DADS + SFN combination exerted synergistic effects in reducing cell viability in HT-29 cells. The DADS + SFN combination is a promising preclinical strategy for evaluating new therapy systems targeted at CRC.

Authors

Publication Details

Journal
Brazilian Journal of Health and Pharmacy
Published
2026-11-19
DOI
https://doi.org/10.68548/bjhp.v8i2026.339
Primary Topic
Genomics, phytochemicals, and oxidative stress
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Effects of combined nutraceuticals on cell viability, migration, and apoptosis in human colorectal cancer cells

Lusânia Maria Greggi Antunes, Estéfani Maria Treviso, Caroline Sanchez, Isabelle Cristine Genari et al.
Brazilian Journal of Health and Pharmacy
Genomics, phytochemicals, and oxidative stress
article

Effects of combined nutraceuticals on cell viability, migration, and apoptosis in human colorectal cancer cells

Lusânia Maria Greggi Antunes, Estéfani Maria Treviso, Caroline Sanchez, Isabelle Cristine Genari, Eduarda Pires
article en

Abstract

Colorectal cancer (CRC), which comprises cancer of the colon and/or rectum, is the third most commonly diagnosed type of cancer. Due to the occurrence of adverse effects and drug resistance, there is a need to find more effective treatments for CRC. Nutraceuticals regulate various metabolic pathways can modulate multiple biomarkers in cancer cells. The present study examined whether diallyl disulfide (DADS) and sulforaphane (SFN), either alone or in combination, were cytotoxic to human colon cancer cells. We assessed DADS (25-800 µM) and SFN (2-32 µM) effects on cell viability (resazurin assay), cell migration (wound healing), and apoptosis (flow cytometry) in human colon adenocarcinoma cells (Caco-2 and HT-29). Synergistic, additive, and antagonistic effects were determined by the combination index (CI) method. The treatment with SFN alone in high concentration reduced cell viability and suppressed cell migration in both cells. The DADS + SFN combination exerted synergistic effects in reducing cell viability in HT-29 cells. The DADS + SFN combination is a promising preclinical strategy for evaluating new therapy systems targeted at CRC.

Brazilian Journal of Health and PharmacyVol. 8(2026)
Genomics, phytochemicals, and oxidative stress
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon